126 related articles for article (PubMed ID: 9181753)
1. Soluble markers of endothelial cell function.
Blann A; Seigneur M
Clin Hemorheol Microcirc; 1997; 17(1):3-11. PubMed ID: 9181753
[TBL] [Abstract][Full Text] [Related]
2. Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus.
Blann AD; Lip GY
Diabet Med; 1998 Aug; 15(8):634-42. PubMed ID: 9702464
[TBL] [Abstract][Full Text] [Related]
3. Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors.
Meyer AA; Kundt G; Steiner M; Schuff-Werner P; Kienast W
Pediatrics; 2006 May; 117(5):1560-7. PubMed ID: 16651309
[TBL] [Abstract][Full Text] [Related]
4. Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus.
Constans J; Dupuy R; Blann AD; Resplandy F; Seigneur M; Renard M; Longy-Boursier M; Schaeverbeke T; Guérin V; Boisseau MR; Conri C
J Rheumatol; 2003 Sep; 30(9):1963-6. PubMed ID: 12966599
[TBL] [Abstract][Full Text] [Related]
5. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
Nadar SK; Al Yemeni E; Blann AD; Lip GY
Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
[TBL] [Abstract][Full Text] [Related]
6. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
Doshi SN; Moat SJ; Lewis MJ; McDowell IF; Giddings JC; Goodfellow J
Int J Cardiol; 2004 Apr; 94(2-3):203-7. PubMed ID: 15093982
[TBL] [Abstract][Full Text] [Related]
7. [Endothelial cell activation and/or injury in multiple sclerosis: analysis with von Willebrand factor and thrombomodulin].
Kohriyama T; Maruyama H; Kurokawa K; Harada T; Nakamura S
Rinsho Shinkeigaku; 1997 Apr; 37(4):287-91. PubMed ID: 9248336
[TBL] [Abstract][Full Text] [Related]
8. Effect of the antioxidants selenium and beta-carotene on HIV-related endothelium dysfunction.
Constans J; Seigneur M; Blann AD; Renard M; Resplandy F; Amiral J; Guérin V; Boisseau MR; Conri C
Thromb Haemost; 1998 Dec; 80(6):1015-7. PubMed ID: 9869176
[TBL] [Abstract][Full Text] [Related]
9. Biochemical markers of endothelial activation in primary hyperparathyroidism.
Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
[TBL] [Abstract][Full Text] [Related]
10. Platelet and endothelial-cell markers in meningococcal septicaemia: a report of two cases.
Blann AD; Amiral J; Taberner DA
Br J Biomed Sci; 2001; 58(1):37-40. PubMed ID: 11284223
[No Abstract] [Full Text] [Related]
11. Circulating endothelial markers and ischemic status in peripheral occlusive arterial disease.
Seigneur M; Boisseau M; Conri C; Lestage B; Amiral J; Constans J
Nouv Rev Fr Hematol (1978); 1995; 37(2):171-3. PubMed ID: 7644357
[TBL] [Abstract][Full Text] [Related]
12. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
Blann AD; Lip GY; Beevers DG; McCollum CN
Thromb Haemost; 1997 Jun; 77(6):1077-80. PubMed ID: 9241735
[TBL] [Abstract][Full Text] [Related]
13. Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm.
Chong AY; Chin BS; Blann AD; Lip GY
Thromb Res; 2005; 116(2):181-3. PubMed ID: 15907534
[No Abstract] [Full Text] [Related]
14. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
[TBL] [Abstract][Full Text] [Related]
15. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
Boos CJ; Balakrishnan B; Lip GY
Ann Med; 2008; 40(1):66-73. PubMed ID: 17934907
[TBL] [Abstract][Full Text] [Related]
16. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia.
Hagag AA; Abdel-Lateef AE; Aly R
J Oncol Pharm Pract; 2014 Oct; 20(5):356-61. PubMed ID: 24243921
[TBL] [Abstract][Full Text] [Related]
18. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
[TBL] [Abstract][Full Text] [Related]
19. Circulating endothelial cells demonstrate an attenuation of endothelial damage by minimizing the extracorporeal circulation.
Skrabal CA; Choi YH; Kaminski A; Steiner M; Kundt G; Steinhoff G; Liebold A
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):291-6. PubMed ID: 16872952
[TBL] [Abstract][Full Text] [Related]
20. Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis.
Bloom BJ; Nelson SM; Eisenberg D; Alario AJ
J Rheumatol; 2005 Feb; 32(2):366-72. PubMed ID: 15693101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]